Parabilis Medicines, Inc. (NASDAQ:PBLS – Get Free Report) Director Alan Sebulsky acquired 9,065 shares of Parabilis Medicines stock in a transaction dated Monday, June 15th. The shares were acquired at an average price of $26.49 per share, with a total value of $240,131.85. Following the completion of the acquisition, the director directly owned 30,000 shares of the company’s stock, valued at approximately $794,700. The trade was a 43.30% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Alan Sebulsky also recently made the following trade(s):
- On Friday, June 12th, Alan Sebulsky acquired 8,435 shares of Parabilis Medicines stock. The shares were acquired at an average price of $27.67 per share, with a total value of $233,396.45.
- On Thursday, June 11th, Alan Sebulsky acquired 12,500 shares of Parabilis Medicines stock. The shares were acquired at an average price of $20.00 per share, with a total value of $250,000.00.
Parabilis Medicines Price Performance
Shares of NASDAQ PBLS opened at $26.59 on Wednesday. Parabilis Medicines, Inc. has a 1 year low of $24.51 and a 1 year high of $34.47.
Featured Stories
- Five stocks we like better than Parabilis Medicines
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for Parabilis Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parabilis Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
